Menu
Log in

Mission:  promote ovarian cancer awareness and education; support those diagnosed and survivors; and advocate for public policy and funding.

Clinical Trials and New Anticancer Treatments (Virtual)

  • 13 May 2024
  • 7:00 PM - 8:15 PM
  • Zoom Audio/Video


Clinical Trials and New Anticancer Treatments

May 13, 7pm-8:15pm

It is a truly remarkable time for developing new treatments for cancer. Increasing understanding of cancer biology and the ability to design new drugs to target abnormalities present in cancer has resulted in a number of novel anticancer drugs being approved by the FDA. There are now drugs that either block specific genetic changes in cancer, modulate the immune system, or represent ways to selectively deliver high doses of chemotherapies to the tumor with acceptable safety profiles. These “new drugs” go through very rigorous testing in the laboratory, and only if they meet certain criteria as anticancer agents, are they brought forward to clinical trials. Early-phase trials are used to test new treatments for cancer while ensuring the highest standards of patient safety. Based on findings in tumor samples and patient characteristics we can now better select new treatments which have a higher likelihood to help patients, a process referred to as ‘personalized medicine’. During this talk we will discuss the concept of personalized medicine, phases of clinical trials, and development of new anticancer treatments.

There will be a Q&A segment after the presentation.

Dr. Jessica Jou is the featured speaker

About Dr. Jessica Jou:

Dr. Jou specializes in the surgical, medical and supportive care of women with gynecologic cancers. She is dedicated to partnering with her patients by listening carefully to their hopes and needs and by providing detailed information on their best treatment options.

Dr. Jou performs open, laparoscopic, and advanced robotic surgeries. She also administers chemotherapy and other anti-cancer treatments.

Her research examines real-world trends in physician practices and patient outcomes. She has a special interest in clinical trials and personalized gynecologic cancer therapies.

Dr. Jou grew up in Taiwan, and loves to visit her family who still live on the beautiful island. She is a certified bilingual Mandarin provider. After completing her residency training in the Bronx and fellowship in San Diego, she moved to the Pacific Northwest with her husband, who is a physician at the Veterans hospital. She loves being outdoors, listening to podcasts, and exploring new cities.

REGISTER HERE

This educational session is being sponsored with the generous support of:


Log in

Ovarian Cancer Alliance of Oregon and Southwest Washington
16420 SE McGillivray, Suite 103, PMB 243  
Vancouver, WA 98683-3461
(877) 682-2679        info@ovariancancerosw.org

We are a registered 501(c)(3) Non-Proft Corporation. EIN: 20-2558493
Copyright © 2005-2019 Ovarian Cancer Alliance of Oregon and Southwest Washington. All rights reserved.

Powered by Wild Apricot Membership Software